What Is Lab Tech PR for Laboratory Information Systems?

Lab tech PR is a specialized form of public relations focused on technology companies operating in laboratory and clinical diagnostics environments. For LIS and LIMS vendors specifically, it means managing and amplifying your brand's reputation among a multi-layered audience that includes clinical laboratory scientists, pathology informatics teams, hospital IT decision-makers, procurement officers, and investors. It is not a generic healthcare PR play — it requires a precise understanding of how laboratories buy software, what problems they are actively trying to solve, and which industry conversations carry the most credibility.

At its core, lab tech PR combines earned media (coverage secured in publications your buyers actually read), thought leadership (positioning your executives and product teams as trusted voices on clinical informatics, automation, and data integrity), and strategic messaging that translates complex technical capabilities into business outcomes. The result is a compounding brand authority that shortens sales cycles, supports investor relations, and makes your company the first name that comes to mind when a laboratory director starts evaluating new systems.

Why PR Matters in the LIS Market

The LIS and LIMS market is no longer a quiet corner of health IT. Cloud-based adoption is accelerating — cloud solutions are forecast to grow at a 6.0% CAGR through 2034 as laboratories seek better scalability, reduced IT overhead, and improved compliance infrastructure. AI-enabled platforms like Xybion's LIMS 10.0, launched in late 2024, are setting new expectations around automation, audit trails, and integrated quality management. Meanwhile, major partnerships — such as LabVantage's integration with SAP PLM for Henkel — signal that the biggest players are racing toward full digital ecosystem connectivity.

In a market evolving this quickly, laboratories are flooded with vendor messaging. A generic pitch about "streamlined workflows" and "improved efficiency" does nothing to differentiate your platform when every competitor says exactly the same thing. Strategic PR cuts through that sameness by finding the specific angles, stories, and expert perspectives that make your brand genuinely interesting to journalists, analysts, and the lab directors reading their work.

PR also plays a critical role during key commercial moments — a product launch, a funding announcement, a major hospital system win, or an expansion into a new market. For a sector where purchasing decisions involve multiple stakeholders and evaluation periods that can stretch for months, maintaining consistent visibility and authority in the right publications is not a luxury. It is a competitive necessity. This is no different from the dynamics we see in fintech PR, where trust and credibility must be built long before a prospect ever enters a sales conversation.

The Unique PR Challenges of LIS and LIMS Companies

Marketing a laboratory information system is fundamentally different from marketing a consumer health app or even a general enterprise SaaS platform. The PR challenges in this space are specific, and ignoring them leads to messaging that either confuses the target audience or fails to generate meaningful coverage.

A Highly Technical Audience With Very Little Patience for Hype

Pathology informatics directors and laboratory managers are scientifically trained professionals who evaluate software against precise functional criteria — HL7 integration, CLIA compliance capabilities, EHR interoperability, sample tracking workflows, and audit trail depth. They are skeptical of marketing language and respond to evidence. Effective PR for LIS vendors speaks to these audiences in a way that is technically credible while still being accessible enough to earn media coverage in mainstream health IT publications. The goal is not to dumb the message down, but to translate it — turning feature depth into patient outcome stories, compliance capability into risk reduction narratives, and integration breadth into operational efficiency wins.

Regulatory Sensitivity That Shapes Every Communication

Laboratory software companies operate in one of the most heavily regulated environments in healthcare technology. Clinical laboratories must comply with CLIA standards, FDA oversight, HIPAA data privacy rules, ISO 15189 requirements, and a patchwork of state and international regulations that constantly evolve. Any PR content — from press releases to thought leadership articles — must be reviewed for accuracy and compliance before publication. Unsubstantiated claims about diagnostic accuracy, test sensitivity, or patient data security are not just marketing missteps; in this sector, they carry legal and reputational risk. A specialist lab tech PR agency understands these guardrails and builds them into the content process from day one, rather than treating compliance as an afterthought.

Long Sales Cycles and Multi-Stakeholder Procurement

Selling an LIS or LIMS to a health system is not a quick transaction. Procurement teams, IT departments, clinical champions, compliance officers, and C-suite executives are all involved in the decision, and each has different priorities. PR must work across all of these audiences simultaneously — building technical credibility with lab scientists, demonstrating ROI for finance teams, and establishing strategic vision for executives evaluating long-term platform relationships. This is why consistent, multi-channel brand presence matters so much. By the time a prospect enters a formal evaluation, they should already know your brand and think of it as a trusted authority, not a new name appearing in their inbox.

A Fragmented Media Landscape

LIS and LIMS vendors must navigate a media landscape that spans clinical laboratory trade publications (MLO, CAP Today, Lab Manager), health IT outlets (Health Data Management, Healthcare IT News), broader business and technology media, and increasingly, scientific journals and analyst reports from firms like Signify Research. Each of these channels requires different content formats, different angles, and different levels of technical depth. Blanket press releases sent without targeting are wasted effort. What works is a media strategy built around genuine relationships with journalists who cover diagnostics, pathology informatics, and health IT — and content that gives them something their readers actually want to read.

Building a Winning PR Strategy for Your LIS Brand

Effective lab tech PR is not reactive. It is a structured, ongoing program that positions your brand for coverage and credibility whether or not you have a product announcement to make. Here is how a results-driven strategy takes shape.

1. Define the Audience Segments and Their Pain Points

LIS marketing must account for the distinct priorities of each stakeholder group. Researchers and laboratory scientists care about workflow accuracy, instrument integration, and peer validation. Laboratory managers and procurement teams prioritize operational efficiency, implementation support, and total cost of ownership. Senior executives and C-suite decision-makers focus on strategic scalability, competitive differentiation, and long-term partnership value. Each of these personas requires tailored messaging and different media touchpoints. A well-structured PR strategy maps your communications to each audience rather than broadcasting one generic message to everyone.

2. Build a Differentiated Brand Narrative

In a market where cloud scalability, AI integration, and EHR connectivity are increasingly table-stakes features, differentiation comes from the story around the product, not just the product itself. Why does your company exist? What clinical problem were you built to solve? What does better laboratory data management actually mean for a patient waiting on a diagnostic result? These narrative layers are what turn product descriptions into compelling editorial — and compelling editorial is what earns coverage. The same principles that drive effective AI PR strategy apply directly here: technical complexity must be anchored to human outcomes to resonate beyond trade publications.

3. Set Measurable Goals Tied to Business Outcomes

PR for lab tech companies should be measured against goals that matter commercially — not just press clippings. Target metrics might include share of voice versus key competitors in clinical laboratory media, inbound leads attributed to earned coverage, backlink authority growth from high-domain health IT publications, or executive visibility scores in relevant analyst communities. Tying PR activity to these outcomes keeps the strategy honest and makes it easier to demonstrate value to leadership teams who are evaluating marketing spend against long-term revenue impact.

4. Align Content to the Buyer Journey

Today's laboratory procurement decision-makers conduct most of their research independently before engaging a vendor. This means content that meets them early — educational white papers on LIS selection criteria, thought leadership pieces on AI in pathology informatics, or data-backed analyses of cloud versus on-premise deployment — builds trust and authority long before a demo is requested. Thought leadership is not just a brand awareness tactic in this sector; it is a direct enabler of pipeline growth.

Thought Leadership: The Most Powerful Tool in Lab Tech PR

In healthtech and life sciences, thought leadership is not about publishing frequently — it is about publishing deliberately. Research from the field consistently shows that substance and depth outperform volume. A single, well-researched article addressing a genuine clinical informatics challenge — say, the integration complexity between LIS and EHR systems, or the cybersecurity implications of cloud-based laboratory platforms — can generate far more credibility and coverage than dozens of shallow feature announcements. The strongest lab tech thought leadership frames content around real questions that laboratory professionals are actually asking, uses clear and evidence-backed analysis, and is authored by executives or clinical experts who carry genuine credentials in the field.

For LIS and LIMS companies, there is no shortage of credible, timely topics. The convergence of AI and laboratory diagnostics is generating enormous interest across both clinical and technology media. Cybersecurity in laboratory environments — particularly following high-profile ransomware attacks that exposed millions of healthcare records — is a growing editorial priority. The shift toward cloud-based LIS, the demand for real-time business analytics within lab platforms, and the role of digital pathology in reshaping LIS architecture all represent genuine opportunities for LIS vendors to contribute expert perspectives that media and analyst audiences actively want. Similar dynamics shape how we approach GreenTech PR and LegalTech PR — every technical sector has a set of macro narratives that expert voices can authentically own, and those who claim them early build authority that is very difficult for competitors to displace.

Media Relations and the Right Publications for LIS Coverage

Strong media relations in lab tech requires a more surgical approach than in consumer technology. The publications that matter to laboratory directors, pathologists, and health IT buyers are specific — and the journalists covering this beat are knowledgeable, skeptical of vendor PR, and highly attuned to whether a pitch offers genuine insight or just product promotion dressed up as news. Building authentic relationships with these journalists, understanding their editorial calendars, and consistently providing them with useful expert commentary — not just press releases — is what generates sustained, high-quality coverage.

The right media strategy for an LIS company typically spans several tiers. Trade publications like MLO (Medical Laboratory Observer), CAP Today, and Lab Manager reach the core technical audience of clinical laboratory professionals. Health IT outlets like Healthcare IT News and Health Data Management reach the informatics and technology buyer audience. Business and general technology media — including vertical tech outlets and national business publications — are increasingly interested in laboratory data as a strategic asset and are publishing more coverage of AI, diagnostics, and digital health infrastructure. A layered approach that targets all three tiers, with content specifically calibrated for each, maximizes both reach and credibility.

Podcast appearances and speaking opportunities at industry events like AACC, HIMSS, and laboratory informatics conferences extend that credibility into audio and live formats, reaching audiences who consume industry insight differently. These channels are particularly valuable for LIS executives looking to establish personal brand authority alongside their company's institutional reputation — a strategy that mirrors what we execute for clients in crypto PR and other complex B2B technology sectors where executive visibility accelerates commercial trust.

Crafting Messaging That Resonates With Technical Buyers

The biggest messaging mistake LIS vendors make is leading with features rather than outcomes. A procurement team evaluating laboratory information systems does not want to be told that your platform has "advanced interoperability modules" — they want to know what happens when their lab is running 10,000 samples a day and the EHR integration fails at 2 a.m. They want to know how your system handles that, what your uptime guarantees look like, and what a comparable hospital system experienced when they switched. That is outcome-based messaging, and it is what converts interest into genuine pipeline movement.

Effective lab tech PR messaging should always anchor technical capabilities to three levels of impact: clinical outcomes (faster turnaround times, reduced diagnostic errors, improved patient safety), operational outcomes (reduced IT burden, lower cost per test, better staff utilization), and strategic outcomes (regulatory compliance assurance, scalability for growth, competitive positioning). When every press release, thought leadership piece, and media pitch speaks to at least one of these levels in concrete, evidence-backed terms, the messaging works across all stakeholder tiers simultaneously — from the lab bench to the boardroom.

Plain language matters too. LIS and LIMS platforms are technically sophisticated, but the best PR content translates that sophistication without oversimplifying it. The goal is precision without jargon — communicating with the confidence of deep expertise rather than obscuring meaning behind technical terminology that excludes broader audiences. This is the same discipline that makes fintech PR effective: financial technology is equally complex, and the brands that win media coverage and investor attention are those that can explain their value clearly to both specialists and generalists.

Why SlicedBrand Is the Right PR Partner for Lab Tech Companies

SlicedBrand is an award-winning global PR agency — recognized by Business Insider as one of the top PR professionals in the technology sector — with a track record built on delivering real coverage and measurable brand growth for innovative technology companies. Our approach combines deep strategic storytelling with extensive media relationships, across both specialist trade channels and top-tier mainstream technology and business publications.

For LIS and LIMS vendors, that means a partner who understands the technical landscape well enough to build credible messaging, knows the media outlets and journalists that your buyers trust, and has the international reach to support global market expansion across North America, Europe, and beyond. Whether you need to build brand awareness ahead of a funding round, establish thought leadership in the clinical informatics space, secure speaking opportunities at major health IT conferences, or manage communications around a major product launch, SlicedBrand brings the strategy and execution to make it happen.

Conclusion

The laboratory information systems market is growing fast, but attention and credibility do not scale automatically with the market. LIS and LIMS vendors that invest in specialized PR — built around differentiated narratives, evidence-backed thought leadership, and authentic media relationships — are the ones that win disproportionate visibility, shorter sales cycles, and stronger investor confidence. In a sector where the technical barriers to entry are high and the buyer journey is long and complex, PR is not a supplementary activity. It is a core growth lever.

If you are ready to build the kind of brand authority that moves the needle in laboratory technology markets, the conversation starts here.